Reduced aldehyde dehydrogenase levels in the brain of patients with Down Syndrome

Journal of Neural Transmission, Supplement

Volumn , Issue 57, 1999, Pages 21-40

  Lubec, G ^c   Labudova, O ^c   Cairns, N ^a   Berndt, P ^b   Langen, H ^b   Fountoulakis, M ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c Building 93 444 ^*

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ACETALDEHYDE; ALDEHYDE; ALDEHYDE DEHYDROGENASE; CARBONYL DERIVATIVE; DIAMINE; DOPAMINE; FRUCTOSE; MESSENGER RNA; NORADRENALIN; OXALIC ACID;

ADULT; ARTICLE; BRAIN LEVEL; BRAIN MAPPING; BRAIN METABOLISM; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DETOXIFICATION; DOWN REGULATION; DOWN SYNDROME; FEMALE; FETUS; HUMAN; HUMAN TISSUE; HYBRIDIZATION; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; TWO DIMENSIONAL GEL ELECTROPHORESIS; AGED; AMINO ACID SEQUENCE; BRAIN; CHEMISTRY; ENZYMOLOGY; GENE LIBRARY; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY;

ADULT; AGED; ALDEHYDE DEHYDROGENASE; AMINO ACID SEQUENCE; BASE SEQUENCE; BRAIN; DOWN SYNDROME; FETUS; GENE LIBRARY; HUMANS; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 0032585808     PISSN: 03036995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254
2. Busciglio J, Yankner BA (1995) Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 378: 776-779
3. Colzi A, Musolino A, Iuliano A, Fornai F, Bonuccelli U, Corsini GU (1996) Identification and determination of 3,4-dihydroxyphenylacetylacetaldehyde, the dopamine metabolite in in vivo dialysate from rat striatum. J Neurochem 66: 1510-1517
4. Epstein CJ (1992) Down Syndrome (Trisomy 21). In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited diseases. McGraw Hill, New York, pp 749-794
5. Esterbauer H, Schaur RJ, Zollner H (1991) Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radic Biol Med 11: 81-128
6. Fountoulakis M, Langen H (1997) Identification of proteins by matrix - assisted laser desorption ionization-mass spectroscopy following in-gel digestion in low-salt, nonvolatile buffer and simplified peptide recovery. Anal Biochem 250: 153-156
7. Hafer G, Agarwal DP, Goeddee HW (1987) Human brain aldehyde dehydrogenase: activity with DOPAL and isoenzyme distribution. Alcohol 4: 413-418
8. Hague NS, LeBlanc CJ, Isacson O (1997) Differential dissecion of the rat E16 ventral mesencephalon and survival and reinnervation of the 6-OHDA - lesioned striatum by a subset of aldehyde dehydrogenase positive TH neurons. Cell Transplant 6: 239-248
9. Harrington CR, Colaco CALS (1994) Alzheimer's disease, a glycation connection. Nature 370: 247-248
10. Kawamura M, Kopin IJ, Kador PF, Sato S, Tjurmina O, Eisenhofer G (1997) Effects of aldehyde dehydrogenase / aldose reductase inhibition on neuronal metabolism of norepinephrine. J Auton Nerv Syst 66: 145-148
11. Kikonyogo A, Pietruszko R (1996) Aldehyde dehydrogenase from adult brain that dehydrogenastes gamma-aminobutyraldehyde: purification, characterization, cloning and distribution. Biochem J 316: 317-324
12. Labudova O, Lubec G (1998) cAMP upregulates the transposable element mys-1: a possible link between signaling and mobile DNA. Life Sci 62: 431-437
13. Langen H, Roeder D, Juranville J-F, Fountoulakis M (1997) Effect of the protein application mode and the acrylamide concentration on the resolution of protein spots separated by two-dimensional gel electrophoresis. Electrophoresis 18: 2085-2090
14. McCaffery P, Drager UC (1994) High levels of retinoic acid-generating dehydrogenase in the meso-telencephalic dopamine system. Proc Natl Acad Sci USA 91: 7772-7776
15. Maring JA, Deitrich RA, Little R (1985) Partial purification and properties of human brain aldehyde dehydrogenase. J Neurochem 45: 1903-1910
16. Mirra SS, Heyman A, McKeel D, Sumi S, Crain BJ (1991) The consortium to establish a registry for Alzheimer disease (CERAD). II. Standardisation of the neuropathological assessment of Alzheimer's disease. Neurology 41: 479-486
17. Nilsson GE, Tottmar O (1985) Biogenic aldehydes in brain: characterization of a reaction betwreen rat brain tissue and indole-3-acetaldehyde. J Neurochem 45: 744-75
18. Nilsson GE, Tottmar O (1987) Biogenic aldehydes in brain: on their preparation and reactions with brain tissue. J Neurochem 48: 1566-1572
19. Petersen DR (1985) Aldehyde dehydrogenase and aldehyde reductase in isolated bovine brain microvessels. Alcohol 2: 79-83
20. Pietruszko R, Meier J, Major LF, Saini N, Manz H, Hawley RJ (1984) Human brain: aldehyde dehydrogenase activity and isoenzyme distribution in different areas. Alcohol 1: 363-367
21. Quintanilla ME, Tampier L (1995) Acetaldehyde metabolism by brain mitochondria from UchA and UchB rats. Alcohol 12: 519-524
22. Rugged P, Saija A, Costa G, Caputi AP (1986) Influence of several aldehyde dehydrogenase and aldehyde reductase inhibitors on diamine oxidase in rat brain. Res Commun Chem Pathol Pharmacol 51: 205-209
23. +-dependent succinic semialdehyde dehydrogenase. Arch Biochem Biophys 266: 386-396
24. Seidl R, Greber S, Schuller E, Bernert G, Cairns N, Lubec G (1997) Evidence against increased oxidative DNA damage in Down Syndrome. Neurosci Lett 235: 137-140
25. Shiohara E, Tsukuda M, Chiba S, Yamazaki H, Nishiguchi K, Miyamoto R, Nakanishi S (1984) Subcellular aldehyde dehydrogenase activity and acetaldehyde oxidation by isolated intact mitochondria of rat brain and liver after acetaldehyde treatment. Toxicol 30: 25-30
26. Smith MA, Sayre LM, Monnier VM, Perry G (1995) Radical AGEing in Alzheimer's disease. Trends Neurosci 18: 172-176
27. Stewart MJ, Malek K, Crabb DW (1996) Distribution of messenger RNAs for aldehyde dehydrogenase 1, aldehyde dehydrogenase 2 and aldehyde dehydrogenase 5 in human tissues. J Invest Med 44: 42-46
28. Tierney MC, Fisher RH, Lewis AJ, Torzitto ML, Snow WG, Reid DW, Nieuwstraaten P, Van Rooijen LAA, Derks HJGM, Van Wijk R, Bischop A (1988) The NINCDA-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease. Neurology 38: 359-36
29. Totmar O (1985) Biogenic aldehydes: metabolism, binding to brain membranes and electrophysiological effects. Prog Clin Biol Res 183: 51-66
30. Vitek MP, Bhattacharya K, Glendening JM, Stopa E, Vlassara H, Bucala R, Manogue K, Cerami A (1994) Advanced glycation end products contribute to amyloidosis in Alzheimer's disease. Proc Natl Acad Sci USA 91: 4766-4770
31. Weiner H, Ardelt B (1984) Distribution and properties of aldehyde dehydrogenase in regions of the rat brain. J Neurochem 42: 109-115
32. Yan SD, Yan SF, Chen X, Fu J, Chen M, Kuppusamy P, Smith D, Perry G, Godman C, Nawroth P, Zweier JL, Stern D (1995) Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide. Nature Med 1: 693-699
33. Zimatkin SM (1991) Histochemical study of aldehyde dehydrogenase in the rat CNS. J Neurochem 56: 1-11
34. Zimatkin SM, Karpuk YG (1996) Regional and cellular distribution of mitochondrial high-affinity aldehyde dehydrogenase in the rat brain. Neurosci Behav Physiol 26: 225-230
35. Zimatkin SM, Rout UK, Koivusalo M, Buehler R, Lindros KO (1992) Regional distribution of low Km mitochondrial aldehyde dehydrogenase in the rat central nervous system. Alcohol Clin Exp Res 16: 1162-1167